NZ's AFT Pharmaceuticals jumps on UK & Hong Kong supply deal
** NZ shares of AFT Pharmaceuticals AFT.NZ jump as much as
2% to NZ$5.10, their highest since Oct 23
** Drug developer signs distribution and supply agreements
for its product Maxigesic IV in UK and Hong Kong urn:newsml:reuters.com:*:nNZWc9mXq
** Says co is targeting sales of the medicine in these
territories in 2022
** As of the previous close, the stock had risen 42.86
percent so far this year
(Reporting by Deepali Saxena)
((Deepali.Saxena@thomsonreuters.com; Twitter:
@deepalisaxenas;))
Recent news on AFT Pharmaceuticals
See all newsAustralia Stock Exchange release from AFT PHARMACEUTIC : FFC: Farmaforce and AFT Pharmaceuticals Partnership
Australia Stock Exchange release from AFT PHARMACEUTIC : Disclosure of Directors & Senior Managers Relevant Interests
Australia Stock Exchange release from AFT PHARMACEUTIC : 2022 New Year letter to investors
Australia Stock Exchange release from AFT PHARMACEUTIC : Disclosure of Directors and Senior Managers Relevant Interes
Australia Stock Exchange release from AFT PHARMACEUTIC : Application for quotation of securities - AFP